Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology Group.
暂无分享，去创建一个
B. Crompton | R. Randall | Alice Yu | M. Diccianni | A. Buxton | L. Teot | K. Janeway | R. Gorlick | M. Krailo | R. Womer | C. Morris | P. Hutson | P. Sondel | S. DuBois | M. Isakoff | P. Hingorani | Michael S. Isakoff